Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP Facebook

The following are excerpts from the newsletter

August 11,1999

  • Measuring medication safety: What works? What doesn't?
  • Hazard Warnings!
  • Writing patient name and location on commercial unit dose product label may foster errors
  • Safe Medication Management Fellow welcomed
  • Safety Briefs:
    • USP and USAN propose name change for amrinone and amiodarone
    • Tip for preventing dispensing errors. Use of highlighter to make sure nothing is overlooked.
    • Our new medication errors book contains section on detecting and measuring errors with various "high alert" medications
    • Gilead Sciences seeks alternate trademark for adefovir dipivoxil, an oral reverse transcriptase inhibitor for AIDS in order to prevent name mixups.
    • Pharmacia and Upjohn's proposed trademark for a new antibiotic, ZYVOX (linezolid), is likely to be confused with Merck's new COX2 inhibitor, VIOXX (rofecoxib).
    • The Pharmaceutical Research and Manufacturer's Association (PhRMA) and FDA are participating in a "Paperless Labeling Task Force." The task force is seeking to replace the current paper package insert with constantly updated electronic versions (PDF files), available exclusively to health professionals via FDA's web site.

August 25,1999

subscribe now

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Newsletter Editions
Acute Care
Long Term Care
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved